Empowered Funds LLC purchased a new position in Varex Imaging (NASDAQ:VREX – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 99,964 shares of the company’s stock, valued at approximately $1,043,000.
Several other large investors have also recently made changes to their positions in the company. Public Employees Retirement System of Ohio purchased a new stake in Varex Imaging during the second quarter valued at approximately $567,000. Bank of America Corp DE purchased a new position in shares of Varex Imaging in the 2nd quarter worth approximately $2,992,000. Man Group plc bought a new position in shares of Varex Imaging during the 2nd quarter valued at approximately $661,000. J. Goldman & Co LP purchased a new stake in Varex Imaging during the 2nd quarter valued at $6,215,000. Finally, Hsbc Holdings PLC purchased a new stake in Varex Imaging during the 2nd quarter valued at $229,000.
Varex Imaging Stock Performance
Varex Imaging stock opened at $18.51 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.53 and a current ratio of 3.38. The company has a market capitalization of $779.27 million, a PE ratio of 35.60 and a beta of 0.96. The company has a 50 day moving average price of $14.00 and a 200-day moving average price of $12.17. Varex Imaging has a fifty-two week low of $9.09 and a fifty-two week high of $18.63.
Wall Street Analyst Weigh In
Several equities research analysts have recently issued reports on VREX shares. Wall Street Zen upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a report on Saturday, July 4th. B. Riley Financial lowered Varex Imaging from a “buy” rating to a “hold” rating in a research report on Monday, August 10th. CJS Securities downgraded Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. Oppenheimer downgraded Varex Imaging from an “outperform” rating to a “market perform” rating in a report on Monday, August 10th. Finally, Zacks Research downgraded Varex Imaging from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 27th. Seven investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $16.88.
Read Our Latest Report on VREX
Varex Imaging Company Profile
Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.
The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.
Read More
- Five stocks we like better than Varex Imaging
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding VREX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varex Imaging (NASDAQ:VREX – Free Report).
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
